Company Applied Genetic Technologies Corporation
Equities
AGTC
US03820J1007
Biotechnology & Medical Research
Business Summary
Number of employees: 102
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 22-10-31 |
David Jacobs
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-07 |
Abraham Scaria
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-14 |
Ashwin Datt
BRD | Director/Board Member | - | 22-11-30 |
Chris Hollowood
BRD | Director/Board Member | 50 | 22-11-30 |
Hope D'Oyley-Gay
LAW | General Counsel | - | 21-11-10 |
Gerald Reynolds
TRE | Treasurer | - | 20-02-29 |
Janet Rae
LAW | General Counsel | - | 21-06-17 |
Matthew Feinsod
PRN | Corporate Officer/Principal | - | 14-06-30 |
Corporate Officer/Principal | 67 | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Fellows
CEO | Chief Executive Officer | 67 | 22-10-31 |
Chris Hollowood
BRD | Director/Board Member | 50 | 22-11-30 |
Ashwin Datt
BRD | Director/Board Member | - | 22-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 67,686,195 | 67,316,723 ( 99.45 %) | 54,000 ( 0.0798 %) | 99.45 % |
Company contact information
Beacon Therapeutics (USA), Inc.
14193 NW 119th Terrace Suite 10
32615, Alachua
+386 462 2204
http://agtc.comSector
1st Jan change | Capi. | |
---|---|---|
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |